Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimin Hu

Showing results (191-200 of 247) with videos related to

Pageof 25
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2025
Unusually Indolent CML: Absence of Complete Cytogenetic Response after 10 Years of Tyrosine Kinase Inhibitor TherapyQiudan Shen, Fadi G Haddad, Elias J Jabbour, et al.
Pathology|July 21, 2022
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasmsHong Fang, Joseph D Khoury, Carlos A Torres-Cabala, et al.
Annals of Hematology|December 30, 2017
Bone marrow findings in blast phase of polycythemia veraJuliana E Hidalgo López, Adrian Carballo-Zarate, Srdan Verstovsek, et al.
British Journal of Haematology|June 1, 2022
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survivalXiaoqiong Wang, Guilin Tang, Zhihong Hu, et al.
Blood Advances|January 4, 2018
Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapyZimu Gong, L Jeffrey Medeiros, Jorge E Cortes, et al.
Oncotarget|February 9, 2018
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphomaWei Liu, Juan Chen, Archito T Tamayo, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Cancers|July 27, 2022
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell NeoplasmWei Wang, Jie Xu, Joseph D Khoury, et al.
Human Pathology|August 27, 2023
Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patientsJi Yuan, Hui Liu, Shimin Hu, et al.
Frontiers in Immunology|June 30, 2023
Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK<sup>-</sup> ALCL vs. CD30<sup>high</sup> PTCL, NOSChenxi Xiang, Wanna Wu, Meiting Fan, et al.
Pageof 25

Showing results (191-200 of 247) with videos related to

Sort By:
Pageof 25
Clinical Lymphoma, Myeloma & Leukemia|May 9, 2025
Unusually Indolent CML: Absence of Complete Cytogenetic Response after 10 Years of Tyrosine Kinase Inhibitor TherapyQiudan Shen, Fadi G Haddad, Elias J Jabbour, et al.
Pathology|July 21, 2022
Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasmsHong Fang, Joseph D Khoury, Carlos A Torres-Cabala, et al.
Annals of Hematology|December 30, 2017
Bone marrow findings in blast phase of polycythemia veraJuliana E Hidalgo López, Adrian Carballo-Zarate, Srdan Verstovsek, et al.
British Journal of Haematology|June 1, 2022
Myeloid neoplasms with 8q24/MYC rearrangement are frequently associated with myelodysplasia, complex karyotype, TP53 alterations, and inferior survivalXiaoqiong Wang, Guilin Tang, Zhihong Hu, et al.
Blood Advances|January 4, 2018
Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapyZimu Gong, L Jeffrey Medeiros, Jorge E Cortes, et al.
Oncotarget|February 9, 2018
Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphomaWei Liu, Juan Chen, Archito T Tamayo, et al.
Oncotarget|March 22, 2018
<i>MET</i> amplification assessed using optimized FISH reporting criteria predicts early distant metastasis in patients with non-small cell lung cancerLianghua Fang, Hui Chen, Zhenya Tang, et al.
Cancers|July 27, 2022
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell NeoplasmWei Wang, Jie Xu, Joseph D Khoury, et al.
Human Pathology|August 27, 2023
Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patientsJi Yuan, Hui Liu, Shimin Hu, et al.
Frontiers in Immunology|June 30, 2023
Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK<sup>-</sup> ALCL vs. CD30<sup>high</sup> PTCL, NOSChenxi Xiang, Wanna Wu, Meiting Fan, et al.
Pageof 25